BILHARZIASIS can be listed as one of the most common diseases encountered in Africa and possibly, perhaps, one of the most serious. It is responsible for much ill health, mostly of a chronic nature, and on occasions leads to death. It is difficult to estimate the mortality rate of the disease in an endemic zone, as such a figure would depend largely on what one accepts as being complications of the disease (e.g. cirrhosis of the liver, bladder cancer and cor pulmonale). From my experience, I would estimate that it is responsible for about I % of deaths in an adult medical ward.
The disease attacks both Europeans and Africans, but as the African comes into contact with the natural waters far more often than the European, who is only exposed to them occasionally for pleasure, as when fishing or picnicking or, very rarely, because of his occupation, the disease naturally assumes a far more serious aspect in the African. There is thus good reason to designate the diseases separately in the two races as European and as African bilharziasis.
African bilharziasis is seen at any age, as no age is immune, but for practical purposes it is a disease of childhood. Yet the infant from birth up to the age of two or three rarely contracts it. This may be because the baby is kept away from infected streams for fear of accidents or because the infant has a natural resistance to the infection. From three to I5 years of age practically every African child in an endemic region may be regarded as having the disease. Thereafter its frequency becomes less and the disease affects 30 to 50% of the adult African population. It is true that, just as there are people living in a badly infected region who do not contract malaria, some Europeans who regularly expose themselves to infected streams do not contract bilharziasis, although their families or friends who have been exposed at the same time succumb to it. Possibly the integument of some humans differs from others, so that it is difficult for the cercarix to penetrate their skins. But there are not many such people and the great majority are easily infected.
Bilharziasis is a self-limiting disease and after about eight years the infection dies out automatically, but, of course, there are the usual exceptions, and cases are recorded in which living worms were found even as long as 20 years after possible exposure. One not uncommonly meets people who remember having had a terminal hamaturia, of which no notice was taken, when they were children and years later all efforts to prove the presence of the disease are fruitless. In such cases it is assumed that the infection has died and little trace has been left.
It generally takes about six weeks from the time of exposure until ova appear in the stool or urine, but one cannot state a precise time when this will occur. Often it is difficult for a patient to remember exactly when exposure took place or even when symptoms first appeared.
In Rhodesia we rarely meet a person who can recall having contracted the local irritation with a papular eruption where the cercarik have penetrated the skin and careful questioning of many reliable witnesses has revealed that in very few instances is there such a history. In Egypt this very early phase is given the special name of Kabure Itch. It is just possible that some of these local reactions at the time of penetration are due to non-human schistosomes rather like those occurring in 'swimmer's itch'. Little mention of the existence of these forms in Africa is made in the literature, but it is possible that they are more common than is generally believed.
When interrogating a patient as to where he was exposed it is of the greatest importance to know the exact site of exposure and how he exposed himself. 
Group i
Patients of this group are seen because of a constitutional or general upset or with symptoms pointing to some other disease. Amongst the better-known symptoms are tiredness, dyspepsia, loss of weight, lack of interest, poor concentration and vague headaches. Very often these patients are labelled as suffering from ' nerves ' or are considered to be making a deliberate attempt to avoid attending school. In this group should be included the early tox2emic phase of the disease, which has been called Katayama disease, although objections have been raised against the use of this term, as, strictly speaking, it applies to a district in the Far East and to the early stages ofjaponicum infection. Another name that has been suggested is ' bilharzial fever'. It affects both sexes and mostly children or youths, and is characterized by a varying degree of fever, iirticaria, lassitude and high eosinophilia. It generally appears about six weeks after exposure and many of these cases are mistaken for typhoid fever or food poisoning. 
Treatment
It is difficult to write about the treatment of bilharziasis, as it depends on so many aspects, such as the patient himself, the duration of the illness, the kind of infestation, whether it is a relatively early or late one and whether it is complicated.
An important factor in the management of any case is whether or not the patient can or is willing to carry out the treatment prescribed. Many Africans refuse prolonged treatment or one that is accompanied by much constitutional upset or is perhaps painful. Frequently many patients are given a full course of treatment and then allowed to return to the environment in which they contracted the disease. Recently I tried, with good effect, an intravenous emetine preparation, Antiamcebiasicum, which proved safe and effective for S. hamatobium, but not for S. mansoni. The patients were not disturbed by its administration and were treated in bed. The preparation used was RO-I-9334, a 2,3-bisdehydroemetine hydrochloride, and it is given as an average daily dose of ioo mg. intravenously for io days. Dosage is based on weight at the rate of I.5 mg./kg. (Gelfand, Reid and Simpson, I962 The treatment of ureteric complications is largely a matter for the urologist, who will determine the degree of bladder tension and so discover whether the ureter is dilated or stenosed. If stenosed, dilatation may help or excision of the lowest portion of the ureter and transplanting it into the bladder may be preferred. If the ureter is dilated and no obstruction present, little is to be gained by interference. When the lower end of the ureter is grossly affected, but not obstructed and yet there is hydronephrosis, excision of the diseased segment, if possible, should be considered, as this may assist an easier flow of urine down the ureter into the bladder. When there is a troublesome nocturnal frequency combined with a high-tension bladder and signs of hydronephrosis the bladder should be enlarged by an ileocystoplastic operation in which a loop of small bowel is attached to the bladder so as to increase its capacity. If this is not done, the hydronephrosis will increase and sooner or later the patient will die of uremia.
The Assessment of Cure
To assess whether a patient is cured of bilharziasis is not easy. In the majority of cases his symptoms improve greatly. His tiredness disappears, his energy returns. A child at school regains his former position in the class. All in all, the person is much happier. This improvement in itself is a valuable indication that the infection has most likely been overcome. It is not absolute proof, as the treatment may have successfully eliminated the great majority of the egg-laying worms, leaving only a few alive which are not sufficient to cause any upset symptomatically. Therefore after the treatment specimens should be tested at six-weekly intervals.
There is no universal agreement as to whether the presence of non-viable ova in the excreta constitutes a cure. Some workers claim that a cure can be assumed if non-viability of the ova is proved. Others believe that cure has not been effected if dead ova are detected. If ova are found in the excreta six weeks after treatment, the disease, in my opinion, is still active. The opposing school of thought claims that dead ova continue to be discharged as foreign bodies for months or even years after the disease has been eliminated. Against this is the fact that hundreds of ova of S. haematobium may be found in the rectal mucosa, although they are hardly ever discharged in the stool. It would seem that dead ova in this tissue fail to find their way out because they no longer secrete enzymes.
Viability of ova found at rectal biopsy is of value as a criterion of cure in cases of S. mansoni, but less frequently so in S. haematobium infections. If dead ova of S.' hmatobium are found in the mucosa after treatment has been completed, there is the possibility that they were there before it commenced.
